Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 14,903 shares of common stock on 03/04/2024, with an aggregate market value of $165,739. The shares to be sold were recently acquired through restricted stock vesting on 03/01/2024 and 03/03/2024, totaling 14,903 shares. This transaction follows a recent sale of 2,465 shares by Watanabe on 02/28/2024, which grossed $26,129.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 14,903 shares of common stock on 03/04/2024, with an aggregate market value of $165,739. The shares to be sold were recently acquired through restricted stock vesting on 03/01/2024 and 03/03/2024, totaling 14,903 shares. This transaction follows a recent sale of 2,465 shares by Watanabe on 02/28/2024, which grossed $26,129.